Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹15,922Cr
Rev Gr TTM
Revenue Growth TTM
31.45%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

ZYDUSWELL
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 11.4 | 0.8 | 2.5 | -3.2 | 9.8 | 19.8 | 12.1 | 14.6 | 16.7 | 2.4 | 32.0 | 108.9 |
| 568 | 586 | 423 | 391 | 620 | 686 | 473 | 447 | 723 | 705 | 628 | 904 |
Operating Profit Operating ProfitCr |
| 20.3 | 16.6 | 3.8 | 3.1 | 20.7 | 18.5 | 4.0 | 3.2 | 20.8 | 18.1 | 3.5 | 6.3 |
Other Income Other IncomeCr | -7 | -12 | 4 | 3 | 4 | 5 | 10 | 4 | 1 | 3 | -33 | -6 |
Interest Expense Interest ExpenseCr | 5 | 5 | 7 | 6 | 6 | 4 | 1 | 3 | 4 | 3 | 16 | 41 |
Depreciation DepreciationCr | 7 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 13 | 11 | 25 | 56 |
| 126 | 93 | 9 | 4 | 154 | 152 | 24 | 10 | 173 | 145 | -51 | -42 |
| -19 | -17 | 3 | 3 | 4 | 4 | 3 | 4 | 2 | 17 | 2 | -2 |
|
Growth YoY PAT Growth YoY% | 9.0 | -19.4 | -30.6 | -98.5 | 3.4 | 33.8 | 254.2 | 2,033.3 | 14.4 | -13.4 | -352.6 | -723.4 |
| 20.4 | 15.7 | 1.3 | 0.1 | 19.2 | 17.6 | 4.2 | 1.4 | 18.8 | 14.9 | -8.1 | -4.1 |
| 4.6 | 3.5 | 0.2 | 0.0 | 4.7 | 4.6 | 0.7 | 0.2 | 5.4 | 4.0 | -1.7 | -1.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -7.9 | 8.5 | 19.1 | 64.4 | 109.6 | 5.7 | 7.6 | 12.2 | 3.2 | 16.4 | 25.1 |
| 331 | 305 | 332 | 387 | 658 | 1,446 | 1,522 | 1,664 | 1,918 | 2,020 | 2,329 | 2,960 |
Operating Profit Operating ProfitCr |
| 23.2 | 23.0 | 23.0 | 24.4 | 21.9 | 18.2 | 18.4 | 17.2 | 14.9 | 13.2 | 14.0 | 12.7 |
Other Income Other IncomeCr | 28 | 32 | 33 | 35 | 28 | -33 | -123 | 10 | -5 | 0 | 20 | -35 |
Interest Expense Interest ExpenseCr | 0 | 0 | 1 | 2 | 30 | 140 | 84 | 26 | 16 | 24 | 12 | 64 |
Depreciation DepreciationCr | 8 | 7 | 7 | 9 | 13 | 26 | 25 | 24 | 25 | 24 | 28 | 105 |
| 120 | 117 | 124 | 150 | 171 | 121 | 112 | 306 | 291 | 260 | 359 | 227 |
| 9 | 12 | 13 | 13 | -1 | -20 | -7 | -3 | -20 | -7 | 12 | 20 |
|
| | -5.3 | 5.7 | 22.7 | 25.4 | -17.2 | -16.2 | 160.1 | 0.5 | -14.0 | 30.0 | -40.3 |
| 25.8 | 26.5 | 25.8 | 26.6 | 20.3 | 8.0 | 6.4 | 15.4 | 13.8 | 11.5 | 12.8 | 6.1 |
| 27.9 | 5.2 | 5.6 | 6.8 | 8.0 | 4.9 | 3.9 | 9.7 | 9.8 | 8.4 | 10.9 | 6.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 39 | 39 | 39 | 39 | 58 | 58 | 64 | 64 | 64 | 64 | 64 | 64 |
| 367 | 439 | 518 | 652 | 3,329 | 3,403 | 4,504 | 4,780 | 5,059 | 5,294 | 5,608 | 5,642 |
Current Liabilities Current LiabilitiesCr | 90 | 75 | 113 | 122 | 546 | 615 | 771 | 767 | 692 | 769 | 746 | 610 |
Non Current Liabilities Non Current LiabilitiesCr | 5 | 5 | 2 | 3 | 1,526 | 1,514 | 328 | 81 | 18 | 22 | 25 | 3,565 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 385 | 433 | 516 | 647 | 698 | 776 | 847 | 814 | 908 | 1,214 | 1,104 | 1,167 |
Non Current Assets Non Current AssetsCr | 123 | 135 | 167 | 182 | 4,761 | 4,814 | 4,820 | 4,878 | 4,925 | 4,934 | 5,338 | 8,715 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 69 | 90 | 77 | 69 | 149 | 259 | 287 | 237 | 92 | 246 | 380 |
Investing Cash Flow Investing Cash FlowCr | 29 | -28 | -72 | -59 | -4,162 | -17 | -10 | -59 | -85 | -178 | -224 |
Financing Cash Flow Financing Cash FlowCr | -27 | -58 | -6 | -2 | 4,052 | -260 | -216 | -234 | -139 | -26 | -186 |
|
Free Cash Flow Free Cash FlowCr | 72 | 86 | 46 | 61 | 132 | 235 | 269 | 162 | 47 | 220 | 315 |
| 62.3 | 85.4 | 69.2 | 50.6 | 87.2 | 182.9 | 241.5 | 76.7 | 29.5 | 92.3 | 109.5 |
CFO To EBITDA CFO To EBITDA% | 69.4 | 98.4 | 77.7 | 55.1 | 80.8 | 80.8 | 83.3 | 68.7 | 27.2 | 80.0 | 100.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 3,967 | 2,903 | 3,396 | 4,583 | 7,487 | 7,479 | 12,553 | 9,550 | 9,862 | 9,360 | 10,636 |
Price To Earnings Price To Earnings | 38.1 | 29.6 | 31.2 | 34.2 | 44.3 | 52.8 | 105.7 | 30.9 | 31.8 | 35.0 | 30.6 |
Price To Sales Price To Sales | 9.2 | 7.3 | 7.9 | 8.9 | 8.9 | 4.2 | 6.7 | 4.8 | 4.4 | 4.0 | 3.9 |
Price To Book Price To Book | 9.8 | 6.1 | 6.1 | 6.6 | 2.2 | 2.2 | 2.8 | 2.0 | 1.9 | 1.8 | 1.9 |
| 36.4 | 28.5 | 30.1 | 33.5 | 48.1 | 27.8 | 37.3 | 28.3 | 30.0 | 30.7 | 28.3 |
Profitability Ratios Profitability Ratios |
| 70.9 | 69.6 | 69.2 | 68.6 | 64.6 | 55.9 | 54.7 | 51.2 | 49.2 | 51.1 | 52.8 |
| 23.2 | 23.0 | 23.0 | 24.4 | 21.9 | 18.2 | 18.4 | 17.2 | 14.9 | 13.2 | 14.0 |
| 25.8 | 26.5 | 25.8 | 26.6 | 20.3 | 8.0 | 6.4 | 15.4 | 13.8 | 11.5 | 12.8 |
| 29.5 | 24.4 | 21.4 | 21.1 | 4.0 | 5.2 | 3.8 | 6.3 | 5.7 | 5.0 | 6.3 |
| 27.4 | 22.0 | 20.0 | 19.8 | 5.1 | 4.1 | 2.6 | 6.4 | 6.1 | 5.0 | 6.1 |
| 21.9 | 18.5 | 16.3 | 16.5 | 3.1 | 2.5 | 2.1 | 5.4 | 5.3 | 4.3 | 5.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Zydus Wellness Ltd. is a leading Indian consumer health and wellness company with a strong pan-India presence and an expanding international footprint. Established in 1988, the company operates across food & nutrition, personal care, and digital wellness, offering functional products that aim to nourish, nurture, and energize consumers. With a robust portfolio of trusted legacy brands and a strategy centered on innovation, digital adoption, and strategic acquisitions, Zydus Wellness continues to outperform both category and market growth.
---
### **Core Business & Brand Portfolio**
Zydus Wellness owns several market-leading brands across key wellness categories:
- **Sugar Free**: Market leader in sugar substitutes with over 95% share in India; expanding into chocolates, cookies, and natural sweeteners.
- **Glucon-D**: Dominant in glucose powder (59–60% market share), now expanding into ready-to-drink (RTD) formats with *Glucon-D Activors*.
- **Nutralite**: India’s leading cholesterol-free fat spread brand, now diversified into dairy (ghee, butter, cheese) and spreads (mayonnaise, chocolate spread).
- **Complan**: High-protein nutritional drink relaunched with scientific claims; growing in both child and adult nutrition (via *ImmunoGro*, *VieMax*).
- **Nycil**: Market leader in prickly heat powder (30–35% share), diversified into soap and personal care.
- **Everyuth**: Leading facial cleansing brand; #1 in scrubs (48.7%) and peel-off masks (77.2%); expanding into skincare (sheet masks, anti-pollution range).
- **RiteBite Max Protein**: Acquired brand leading in healthy snacking, with protein bars, cookies, and chips.
---
### **Strategic Initiatives & Expansion (2025)**
#### **1. Acquisition of Comfort Click (Aug 2025)**
- Zydus Wellness completed its **first overseas acquisition** by acquiring **Comfort Click Limited**, a UK-based digital-first VMS (Vitamins, Minerals, Supplements) company.
- **Deal Value**: GBP 239 million (equity).
- **Target Profile**:
- Operates in UK, EU, and expanding into the USA.
- GBP 134 million unaudited revenue (FY2025); 57% five-year CAGR.
- Recognized in the *Financial Times’ Top 1000 Fastest-Growing Companies in Europe (2024 & 2025)*.
- **Brands under Comfort Click**:
- **WeightWorld**: Plant-based, sports, and adult VMS.
- **maxmedix**: Paediatric VMS gummies.
- **Animigo**: Natural pet health supplements.
- **Strategic Impact**:
- Strengthens Zydus’s position in global digital wellness.
- Expands addressable market into the **GBP 11 billion European VMS sector**.
- Enables entry into adult, child, and pet wellness via e-commerce and D2C channels.
- Supports long-term goal of 8–10% of total revenue from international markets.
#### **2. Acquisition of Naturell (India) Pvt. Ltd. (NIPL) / RiteBite**
- Acquired 100% of **Naturell (India) Pvt. Ltd. (NIPL)** in FY2024–25 for ₹3,900 crore.
- NIPL owns **RiteBite Max Protein** and **RiteBite**, a pioneer in India’s protein bar market.
- Post-acquisition integration is on track, with strong performance and digital transformation underway.
- The brand is scaling rapidly via e-commerce, digital marketing, and fitness influencer partnerships.
---
### **Growth Drivers & Performance (2025)**
- **Double-Digit Growth**: Achieved for six consecutive years, driven by volume-led category expansion.
- **Excluding seasonal and acquired brands, organic growth remains strong**.
- **International Momentum**: Despite macroeconomic challenges in Nigeria, operations continue to grow; Middle East and SAARC markets show robust performance.
- **RiteBite Max Protein International Expansion**: Successfully launched in key markets, receiving positive early feedback.
---
### **Digital & Innovation Focus**
- **AI-Powered Engagement**: Launched an **AI recipe platform** that suggests recipes via food photo uploads or WhatsApp messages—used for Nutralite and Nycil.
- **Celebrity Partnerships**: Collaborations with Chef Sanjeev Kapoor and actor Kartik Aaryan (RiteBite) enhance digital and mass appeal.
- **E-commerce & Quick Commerce**:
- E-commerce contributes ~10% of total sales.
- Quick commerce dominates 41.4% of e-commerce sales due to lower cost-to-serve.
- High ratings (>4.6) on Amazon across major European markets.
- **Digital R&D & Product Development**:
- State-of-the-art R&D center in Ahmedabad.
- 12 new product launches in FY2024–25.
- Focus on "Good for You" innovations, clinical validation, and sustainability.
---
### **Recent Product Launches (2025)**
- **Nutralite Activ Peanut Butter**: Plant-based, multiple flavors.
- **RiteBite Millet Wafer Protein Bars**: 10g protein, no maida, no palm oil, zero added sugar.
- **Complan VieMax**: Adult nutrition drink with high protein, prebiotics, probiotics; clinically proven.
- **Glucon-D Activors**: RTD electrolyte energy drink.
- **Everyuth Sheet Masks**: Golden Glow, Anti-Pollution, Aloe Cucumber variants.
---
### **Distribution & Market Presence**
- **India**:
- Direct distribution to **6.1–6.2 lakh outlets**, aiming for 7 lakh.
- Products available in **over 2.8 million retail outlets** (Nielsen); target of 3.5–4 million.
- Pan-India cold chain network with **25 integrated warehouses**.
- 1,950+ distributors, 2,800+ field force.
- **Global**:
- Exports in **25+ countries** (MEA, SAARC, SEA, Oceania).
- **Sugar Free** and **Complan** drive ~85–90% of international revenue.
- **Nigeria, UAE, Saudi Arabia, Bangladesh** among top 5 markets.
---
### **Market Share Performance (Nov 2025)**
- **Nycil**: Market share increased from 30% to 33% post-acquisition; strong double-digit growth.
- **Complan**: Maintaining share in key regions; growth in UP, Bihar; challenged in West Bengal.
- **Glucon-D**: Growing 1.5–2x faster than pre-acquisition; repositioning into RTD.
- **Everyuth Scrub**: 48.7% market share (+ basis points YoY); ranked **#5 in facial cleansing** (Nielsen, June 2025).
- **Sugar Free**: >95% share in sugar substitutes; aims to be a **global top 3 brand**.
---
### **Organizational & Operational Strategy**
- **Digitization**: End-to-end digitization across sourcing, distribution, and sales.
- **Predictive Analytics**: Building capabilities to improve forecasting and decision-making.
- **Supply Chain Optimization**: Disintermediation in organized trade; reduced cost-to-serve.
- **Integrated Business Planning (IBP)**: Implemented for demand-supply alignment.